- Design
- Prospective cohort analysis
- Population
- 3,826 adults with CKD in the CRIC study
- Primary outcome
- Heart failure, kidney outcomes, new diabetes
- Effect
- Highest vs middle tertile: kidney HR 1.19 (1.09-1.30); atherosclerotic HR 1.34 (1.09-1.64)
An analysis of the Chronic Renal Insufficiency Cohort, published in Kidney International on 20 October 2026, measured plasma hepcidin in 3,826 people with CKD and followed them for heart failure, kidney failure or halving of eGFR, new diabetes, atherosclerotic events and death.
Higher hepcidin went with older age, diabetes, lower eGFR, more albuminuria, higher iron indices and more inflammation. It was not associated with heart failure or new diabetes. Against the middle third, the highest third was associated with kidney outcomes (HR 1.19, 95% CI 1.09 to 1.30) and atherosclerotic events (HR 1.34, 1.09 to 1.64), and the lowest third with higher all-cause and cardiovascular mortality, after adjusting for iron and inflammation.
The U-shaped pattern suggests hepcidin reflects several processes rather than one. It is not a test for routine use, but it adds to the case that iron handling in CKD matters beyond anaemia.
- Do not order hepcidin routinely in CKD; it is a research marker.
- Assess iron status with ferritin and transferrin saturation as usual.
- Interpret ferritin with care in inflamed patients, where it may not reflect iron stores.
- Treat iron deficiency in CKD according to current guidance.
Why it matters
It hints that iron regulation links to kidney and vascular outcomes, not only to anaemia.
Don't overread it
Observational associations — it does not show that changing hepcidin would change outcomes.
The statistics, in plain English
A hazard ratio of 1.19 is a modest increase in risk. Comparing extreme thirds with the middle can exaggerate patterns, and a U-shape often reflects different underlying illnesses at each end.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for nephrology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free